Dr. Bahar Laderian
Overview
Bahar Laderian is a Hematologist Oncology provider in Cleveland, Ohio. Dr. Laderian is rated as an Advanced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Her top areas of expertise are Glomus Tympanum Tumor, Glomus Jugulare Tumor, Lynch Syndrome, Gastroesophageal Junction Cancer, and Gamma Knife Radiosurgery.
Her clinical research consists of co-authoring 4 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
9500 Euclid Avenue, Cleveland, OH 44195
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Cleveland Clinic Main Campus
Michael Mcnamara is a Hematologist Oncology provider in Cleveland, Ohio. Dr. Mcnamara has been practicing medicine for over 28 years and is rated as a Distinguished provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Melanoma of the Eye, Lynch Syndrome, and Gamma Knife Radiosurgery.
Cleveland Clinic Main Campus
Marc Shapiro is a Gastroenterologist in Cleveland, Ohio. Dr. Shapiro is rated as a Distinguished provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Liver Embolization.
Cleveland Clinic Main Campus
Joel Saltzman is a Hematologist Oncology provider in Cleveland, Ohio. Dr. Saltzman has been practicing medicine for over 33 years and is rated as a Distinguished provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Lung Cancer, Lynch Syndrome, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Gastroesophageal Junction CancerDr. Laderian isAdvanced. Learn about Gastroesophageal Junction Cancer.
- Glomus Jugulare TumorDr. Laderian isAdvanced. Learn about Glomus Jugulare Tumor.
- Glomus Tympanum TumorDr. Laderian isAdvanced. Learn about Glomus Tympanum Tumor.
- Lynch SyndromeDr. Laderian isAdvanced. Learn about Lynch Syndrome.
- Experienced
- Adrenal CancerDr. Laderian isExperienced. Learn about Adrenal Cancer.
- ALK-Positive Non-Small Cell Lung CancerDr. Laderian isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Laderian isExperienced. Learn about Anal Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Laderian isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Dubin-Johnson SyndromeDr. Laderian isExperienced. Learn about Dubin-Johnson Syndrome.
- EGFR Positive Lung CancerDr. Laderian isExperienced. Learn about EGFR Positive Lung Cancer.